Clinical trial
Duration of Maintenance Anti-psychotic Therapy After First -Episode Schizophrenia: a Double-blind Randomized Placebo-control Relapse Prevention Study
NCT00334035 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Duration of Maintenance Anti-psychotic Therapy After First -Episode Schizophrenia: a Double-blind Randomized Placebo-control Relapse Prevention Study
- Lead sponsor
- The University of Hong Kong
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2003
- Completion date
- June 30, 2007
- Enrollment
- 169 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.